Risk factors for and pregnancy outcomes after SARS‐CoV‐2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS‐CoV‐2 diagnosis
Acta Obstetricia Et Gynecologica Scandinavica2023Vol. 102(3), pp. 282–293
Citations Over TimeTop 10% of 2023 papers
Anna J. M. Aabakke, Tanja Gram Petersen, Karen R. Wøjdemann, Mette Holm Ibsen, Fjòla Jònsdòttir, Elisabeth Rønneberg, Charlotte Sander Andersen, Anne Hammer, Tine D. Clausen, Julie Milbak, Lars Burmester, Rikke Zethner, Birgitte Lindved, Annette Thorsen‐Meyer, Mohammed Rohi Khalil, Birgitte Henriksen, L. Jönsson, Lise L. T. Andersen, Kamilla Karlsen, Monica L. Pedersen, Gitte Hedermann, Marianne Vestgaard, Dorthe Thisted, Agnethe N. Fallesen, Josephine N. Johansson, Ditte C. Møller, Greta Dubietyte, Charlotte Brix Andersson, Richard Farlie, Ane‐Kersti Skaarup Knudsen, Lea Kirstine Hansen, Lone Hvidman, Anne Sørensen, Sidsel Linneberg Rathcke, Katrine Hass Rubin, Lone Kjeld Petersen, Jan Stener Jørgensen, Lone Krebs, Mette Bliddal
Abstract
Women infected with SARS-CoV-2 during pregnancy were at increased risk of hypertensive disorders in pregnancy, early pregnancy loss, preterm delivery and having children small for gestational age. The validity of Danish national registers was acceptable for identification of SARS-CoV-2 infection during pregnancy.
Related Papers
- → Chilblain‐like lesions after BNT162b2 mRNA COVID‐19 vaccine: a case report suggesting that ‘COVID toes’ are due to the immune reaction to SARS‐CoV‐2(2021)26 cited
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → Особенности сахароснижающей фармакотерапии у пациентов с SARS-CoV-2 (COVID-19)(2021)
- → Спонтанний пневмоторакс у хворих на нову коронавірусну хворобу SARS-CoV-2 COVID-19(2022)